First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells
Wu J(吴骏); Hu Zhongjie; Wang L(王柳); Tan YQ(谭元卿); Hou Wei; Li ZW(李仲文); Gao TT(高婷婷); Fan JQ(范佳琪); Guo BJ(郭保杰); Dai Huaping
刊名CELL PROLIFERATION
2020
卷号53期号:12页码:e12943
内容类型期刊论文
源URL[http://ir.ioz.ac.cn/handle/000000/14489]  
专题干细胞与生殖生物学国家重点实验室
推荐引用方式
GB/T 7714
Wu J,Hu Zhongjie,Wang L,et al. First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells[J]. CELL PROLIFERATION,2020,53(12):e12943.
APA 吴骏.,Hu Zhongjie.,王柳.,谭元卿.,Hou Wei.,...&胡宝洋.(2020).First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells.CELL PROLIFERATION,53(12),e12943.
MLA 吴骏,et al."First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells".CELL PROLIFERATION 53.12(2020):e12943.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace